Technology · en
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Related index pages
Technology · EngadgetVRChat says it's not adding AI labels despite user survey showing people want that
Trying to make everyone happy could make no one happy.Read original ↗
World · Blaze Media9th Circuit denies Trump DOJ's demand for California to set aside likely noncitizen ballots — but it's not over
The Trump administration lost a bid to force California to set aside ballots from a list of likely noncitizen voters.…Read original ↗
Technology · WIREDThere’s a Completely New Type of Whisky. It’s French and Made in Concrete Eggs
The founders of Maison Lineti are, in a world first, making single malt whisky as if it were wine—and the spirit world is mighty impressed.Read original ↗
Technology · The DecoderMicrosoft offers a quarter of its workforce voluntary severance while shielding AI-critical teams
Microsoft is offering voluntary severance packages to about 60,000 employees, roughly a quarter of its workforce, in the second such program this year.…Read original ↗
Technology · The DecoderOpenAI raises just $11 billion of its $30 billion target as big investors lose their AI appetite
OpenAI raised only about $11 billion in its latest funding round, less than half of the $30 billion it was targeting. At $1.…Read original ↗
Technology · WIRED